Good afternoon, and welcome to the Relmada Therapeutics Fourth Quarter and Full Year 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results